P0347: Correlation between histologic disease activity in the distal and proximal colon in Ulcerative Colitis: A flexible sigmoidoscopy is insufficient to assess histologyECCO'25Year: 2025
Authors: De Marco, D.(1)*;Meadler Kron, C.(2);Marcus, V.(2);Bitton, A.(1);Lakatos, P.(1);Wild, G.(1);Afif, W.(1);Bessissow, T.(1);
(1)McGill University, Gastroenterology and Hepatology, Montreal, Canada;(2)McGill University, Pathology, Montreal, Canada;
P0348: Ultrasound enterography with a novel ultrasound contrast agent for Crohn's DiseaseECCO'25Year: 2025
Authors: Gjengstoe, A.J.(1)*;Volkmann, H.L.V.(1);Aziz, A.(2);Dimcevski, G.(3);Gilja, O.H.(1);Nylund, K.(1);
(1)Haukeland University Hospital, Medical Department, Bergen, Norway;(2)Deaconess Home Hospital Haraldsplass, Medical Department, Bergen, Norway;(3)Kanalspesialistene, Kanalspesialistene, Bergen, Norway;
1. Van Deen WK et. Al. Development and Validation of an Inflammatory Bowel Diseases Monitoring Index for Use With Mobile Health Technologies. Clin Gastroenterol Hepatol. 2016 Dec;14(12):1742-1750.e7. doi: 10.1016/j.cgh.2015.10.035.
P0349: Gasdermin D: A New Inflammatory Biomarker in Assessing Clinical Disease Activity in Crohn’s DiseaseECCO'25Year: 2025
Authors: Buldukoglu , O.C.(1);Ocal , S.(1);Atar , G.E.(1);Kaya , B.(1);Isik , M.D.(1);Aydin Tigli , G.(2);Akca , S.(1);Akbay Harmandar , F.(1);Cekin , Y.(2);Cekin , A.H.(1)*;
(1)Antalya Training and Research Hospital, Gastroenterology, Antalya, Turkey;(2)Antalya Training and Research Hospital, Medical Microbiology, Antalya, Turkey;
1. Roda G, Chien Ng S, Kotze PG, Argollo M, Panaccione R, Spinelli A, et al. Crohn's disease. Nat Rev Dis Primers. 2020 Apr 2;6(1):22.
2. Dai Z, Liu WC, Chen XY, Wang X, Li JL, Zhang X. Gasdermin D-mediated pyroptosis: mechanisms, diseases, and inhibitors. Front Immunol. 2023 May 18;14:1178662.
3. Zhang S, Liang Y, Yao J, Li DF, Wang LS. Role of Pyroptosis in Inflammatory Bowel Disease (IBD): From Gasdermins to DAMPs. Front Pharmacol. 2022 May 23;13:833588.
4. Gao X, Wang C, Shen XT, Li CY, Li YC, Gao H, et al. Pyroptosis burden is associated with anti-TNF treatment outcome in inflammatory bowel disease: new insights from bioinformatics analysis. Sci Rep. 2023 Sep 22;13(1):15821.
P0350: Asia Pacific Association of Gastroenterology consensus statements on histopathological evaluation of Inflammatory Bowel DiseasesECCO'25Year: 2025
Authors: Leong, R.(1);Chaemsupaphan, T.(2)*;Lin, H.(3);Lim, W.C.(3);Ooi, C.J.(4);Chetwood, J.D.(1);Mao, R.(5);Wu, H.Y.(6);Wei, S.C.(7);Makharia, G.(8);Ahuja, V.(8);Banerjee, R.(9);Limsrivilai, J.(2);Aniwan, S.(10);Pisespongsa, P.(11);Hilmi, I.(12);Raja Ali, R.A.(13);Leung, W.K.(14);Ng, S.(15);Ye, B.D.(16);Kobayashi, T.(17);Matsuoka , K.(18);Chau, C.(19);Sanpavat, A.(20);Shun, C.T.(21);Puspanathan , P.(22);Gearry, R.B.(23);Danese, S.(24);Ma, C.(25);Pudipeddi, A.(1);Paramsothy, S.(1);
(1)Concord Repatriation General Hospital, Gastroenterology and Liver Services, Sydney, Australia;(2)Siriraj Hospital Mahidol University, Medicine, Bangkok, Thailand;(3)Tan tock Seng hospital, Gastroenterology, Singapore, Singapore;(4)Duke-NUS Medical School, Gastroenterology, Singapore, Singapore;(5)First Affiliated Hospital of Sun Yat-sen University, Gastroenterology, Guangzhou, China;(6)National Taiwan University Hospital Jinshan branch, Internal Medicine, New Taipei, Taiwan;(7)National Taiwan University Hospital, Internal Medicine, Taipei, Taiwan;(8)All India institute of Medical Sciences, Gastroenterology and Human Nutrition, New Delhi, India;(9)Asian Institute of Gastroenterology, Gastroenterology, Hyderabad, India;(10)Chulalongkorn University and King Chulalongkorn Memorial Hospital, Gastroenterology, Bangkok, Thailand;(11)King Mongkut's Institute of Technology Ladkrabang, Medicine, Bangkok, Thailand;(12)University Malaya, Medicine, Kuala Lumpur, Malaysia;(13)Sunway University, Medicine, Subang Jaya, Malaysia;(14)Li Ka Shing Faculty of Medicine- The University of Hong Kong, Medicine, Hong Kong, Hong Kong- China;(15)State Key Laboratory of Digestive Disease- Li Ka Shing Institute of Health Sciences- Institute of Digestive Disease- The Chinese University of Hong Kong, Medicine and Therapeutics, Hong Kong, Hong Kong- China;(16)Asan Medical Center- University of Ulsan College of Medicine, Gastroenterology, Seoul, Korea- Republic Of;(17)Kitasato University Kitasato Institute Hospital, Gastroenterology, Tokyo, Japan;(18)Toho University Sakura Medical Center, Internal Medicine, Chiba, Japan;(19)Tan Tock Seng Hospital, Pathology, Singapore, Singapore;(20)Chulalongkorn University, Pathology, Bangkok, Thailand;(21)National Taiwan University Hospital, Forensic Medicine and Pathology, Taipei, Taiwan;(22)Hospital Pulau Pinang, Pathology, Penang, Malaysia;(23)University of Otago, Medicine, Christchurch, New Zealand;(24)IRCCS Ospedale San Raffaele, Gastroenterology and Endoscopy, Milan, Italy;(25)Cumming School of Medicine- University of Calgary, Medicine, Calgary, Canada;
P0351: Differential Cutoff Values of Fecal Calprotectin Based on Disease Extent of Ulcerative ColitisECCO'25Year: 2025
Authors: Lee, J.(1)*;Kim, S.J.(2);Lee, M.H.(3);
(1)College of Medicine- Chosun University, Divisoin of Gastroenterology- Department of Internal Medicine, Gwangju, Korea- Republic Of;(2)College of Medicine- Chosun University, Division of gastroenterology- Department of Internal medicine, Gwangju, Korea- Republic Of;(3)College of Medicine- Chosun univeristy, Division of gastroenterology- Department of Internal Medicine, Gwangju, Korea- Republic Of;
1. Lichtenstein GR, Rutgeerts P. Importance of mucosal healing in ulcerative colitis. Infamm Bowel Dis. 2010;16:338–46.
2. Lee J. [Fecal Calprotectin in Inflammatory Bowel Disease]. Korean J Gastroenterol. 2016 May 25;67(5):233-7.
3. Walsh A, Kormilitzin A, Hinds C, et al. Defning faecal calprotectin thresholds as a surrogate for endoscopic and histological disease activity in ulcerative colitis—a prospective analysis. J Crohn’s Colitis. 2019;13:424–30.
4. Mosli MH, Zou G, Garg SK, et al. C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis. Am J Gastroenterol. 2015 Jun;110(6):802-19
5. Sonoyama H, Kawashima K, Ishihara S, et al. Capabilities of fecal calprotectin and blood biomarkers as surrogate endoscopic markers according to ulcerative colitis disease type. J Clin Biochem Nutr. 2019 May;64(3):265-270
P0352: Fecal calprotectin and pseudopolyps in Ulcerative Colitis: Is there a relationship?ECCO'25Year: 2025
Authors: Crespo, A.(1)*;Pèlach, A.(2);Vidal, M.(2);Calafat, M.(2);Llaó, J.(2);Domènech, E.(2);Mañosa, M.(2);
(1)Dénia Hospital, Gastroenterology Department, Dénia, Spain;(2)Germans Trias i Pujol University Hospital, Gastroenterology Department, Badalona, Spain;
P0353: Correlation between qUality of life and point of cAre intestinaL ultrasound In patients wiTh inflammatorY bowel disease (CUALITY)ECCO'25Year: 2025
Authors: Parra Izquierdo, L.V.(1,2,3)*;Ernest Suarez , K.(4);Argollo, M.(5);Frías-Ordoñez, J.(6);Orduz, G.(7);Puentes Manosalva, F.(8);Cubillos, S.(9);Verstockt , B.(1,3);
(1)KU Leuven Department of Chronic Diseases and Metabolism- Translational Research Center for Gastrointestinal Disorders TARGID, Department of Chronic Diseases and Metabolism, Leuven, Belgium;(2)Hospital Internacional de Colombia, Gastroenterology and Rheumatology, Bucaramanga, Colombia;(3)University Hospitals Leuven- Department of Gastroenterology and Hepatology- KU Leuven, Gastroenterology, Leuven, Belgium;(4)School of Medicine- University of Costa Rica, Gastroenterology, San Jose, Costa Rica;(5)Universidade Federal de São Paulo, Gastroenterology, Sao Paulo, Brazil;(6)National University of Colombia, Gastroenterology, Bogotá, Colombia;(7)Hospital Internacional de Colombia, Center of Excellence in IBD, Bucaramanga, Colombia;(8)Unión de Cirujanos. ODO. Zentria Salud -Universidad de Caldas, Gastroenterology, Manizales, Colombia;(9)Hospital Internacional de Colombia, Radiology, Bucaramanga, Colombia;
P0354: Mild cognitive impairment occurs in patients with inflammatory bowel disease irrespective of disease activityECCO'25Year: 2025
Authors: Compare, D.(1);Sgamato, C.(1);Minieri, S.(1)*;Marchitto, S.A.(1);Cinque, S.(1);Ambrosio, C.(1);Zerella, G.(1);Nardone, G.(1);
(1)University Federico II of Naples, Department of Clinical Medicine and Surgery- Gastroenterology, Naples, Italy;
P0355: Comparison between patients with Inflammatory Bowel Disease, Spondyloarthritis or both pathologies; our experience.ECCO'25Year: 2025
Authors: Bertani, A.(1);Pecchini, M.(1)*;Angri, A.(2);Gilda, S.(3);Giuggioli, D.(3);Colecchia, A.(1);
(1)University Hospital of Modena, Gastroenterology Unit, Modena, Italy;(2)University Hospital of Modena, University of Modena, Modena, Italy;(3)University Hospital of Modena, Rheumatology Unit, Modena, Italy;
Huppertz-Hauss G, Høivik ML, Jelsness-Jørgensen LP, Opheim R, Henriksen M, Høie O, et al. Fatigue in a population-based cohort of patients with inflammatory bowel disease 20 years after diagnosis: The IBSEN study. Scand J Gastroenterol. 2017;52(3):351–8
Grimstad T, Norheim KB, Isaksen K, Leitao K, Hetta AK, Carlsen A, et al. Fatigue in Newly Diagnosed Inflammatory Bowel Disease. J Crohns Colitis. 2015;9(9):725–30
Ossum AM, Palm Ø, Cvancarova M, Bernklev T, Jahnsen J, Moum B, et al. The Impact of Spondyloarthritis and Joint Symptoms on Health-Related Quality of Life and Fatigue in IBD Patients. Results From a Population-Based Inception Cohort (20-Year Follow-up in the Ibsen Study). Inflamm Bowel Dis. 2020;26(1):114–24
P0356: A case of pulmonary nodules in Ulcerative Colitis and primary sclerosing cholangitis: is it drug or disease?ECCO'25Year: 2025
Authors: Badrulhisham, F.(1)*;Bhushan, A.(2);Djouider, Y.(2);Metwally, A.(2);Digby-Bell, J.(2);
(1)Exeter IBD Pharmacogenetics and Research Group, Gastroenterology, Exeter, United Kingdom;(2)Royal Devon and Exeter Hospital, Gastroenterology, Exeter, United Kingdom;
P0357: Comparing Surgical Outcomes Between Crohn’s disease and Gastrointestinal Behçet’s disease: A Single-Center Retrospective Cohort StudyECCO'25Year: 2025
Authors: Shin, D.H.(1)*;Kang, S.(1);Kim, J.(1);Bae, H.W.(1);Park, M.Y.(1);Yang, S.Y.(1);Han, Y.D.(1);Hur, H.(1);Min, B.S.(1);Cho, M.S.(1);
(1)Yonsei University College of Medicine- Severance Hospital, Department of Surgery- Division of Colon and Rectal Surgery, Seoul, Korea- Republic Of;
Yazisiz V. Similarities and differences between Behçet's disease andCrohn's disease. World J Gastrointest Pathophysiol. 2014.15; 5(3): 228-238.
Baek SJ, Kim CH, Cho MS et al. Surgical Treatment and Outcomes in Patients WithIntestinal Behçet Disease: Long-term Experience ofa Single Large-Volume Center. Dis Colon Rectum 2015; 58: 575–581DOI: 10.1097
Zeng L, Meng WJ, Wen ZH et al. Management and outcomes of surgical patients with intestinalBehçet’s disease and Crohn’s disease in southwest China. World J Clin Cases. 2021; 9(16): 3858-3868.
P0358: The effects of reading experience on small intestine capsule endoscopy scoring of Crohn’s diseaseECCO'25Year: 2025
Authors: Wada, H.(1)*;Omori, T.(1,2);Mitsui, T.(1);Hayashida, M.(1);Matsuura, M.(1);Hisamatsu, T.(1);
(1)Kyorin University School of Medicine, Department of Gastroenterology and Hepatology, Mitaka-shi, Japan;(2)Kyorin University Suginami Hospital, Department of Gastroenterology and Hepatology, Suginami-ku, Japan;
P0359: Characteristics and long-term outcomes of biopsy proven serrated epithelial change in patients with inflammatory bowel disease: a retrospective analysisECCO'25Year: 2025
Authors: Vaitiekunas, L.(1)*;Kakkadasam Ramaswamy, P.(1);Pillai, S.(2);Willis, T.(2);Mohsen, W.(1);
(1)Gold Coast University Hospital, Digestive Health, Southport, Australia;(2)Gold Coast University Hospital, Department of Pathology, Southport, Australia;
1. Johnson DH, Khanna S, Smyrk TC, et al. Detection rate and outcome of colonic serrated epithelial changes in patients with ulcerative colitis or Crohn’s colitis. Alimentary Pharmacology & Therapeutics. 2014;39(12):1408-1417. doi:10.1111/apt.12774
2. Parian A, Koh J, Limketkai BN, et al. Association between serrated epithelial changes and colorectal dysplasia in inflammatory bowel disease. Gastrointestinal Endoscopy. 2015;84(1):87-95.e1. doi:10.1016/j.gie.2015.12.010
P0360: Bowel Ultrasonography and Computed Tomography tell the same story using different languages in analizing Crohnˈs disease lesionsECCO'25Year: 2025
Authors: Les, A.(1)*;Sarbu, A.M.(2);Dumitru, R.(2);Saizu, R.(3);Gheorghe, L.(1);Gheorghe, C.(1);
(1)Fundeni Clinical Institute, Gastroenterology, Bucharest, Romania;(2)Fundeni Clinical Institute, Radiology, Bucharest, Romania;(3)Carol Davila University of Medicine and Pharmacy, Gastroenterology, Bucharest, Romania;
P0361: Clinical outcomes of acute severe colitis in Latin American: a case series.ECCO'25Year: 2025
Authors: Burmann, B.P.(1);Barros, L.L.(1)*;Romero, A.E.P.(1);Salgado, J.G.D.(1);Prado, R.D.C.P.(1);Mattos, P.S.L.D.(1);Azevedo, M.F.C.D.(1);Carlos, A.D.S.(1);Damião, A.O.M.C.(1);
(1)University of São Paulo School of Medicine, Department of Gastroenterology and Nutrology, São Paulo, Brazil;
1. Quaresma AB, Damiao AOMC, Coy CSR, Magro DO, Hino AAF, Valverde DA, Panaccione R, Coward SB, Ng SC, Kaplan GG, Kotze PG. Temporal trends in the epidemiology of inflammatory bowel diseases in the public healthcare system in Brazil: A large population-based study. Lancet Reg Health Am. 2022 Jun 9;13:100298.
2. Rivière P, Li Wai Suen C, Chaparro M, De Cruz P, Spinelli A, Laharie D. Acute severe ulcerative colitis management: unanswered questions and latest insights. Lancet Gastroenterol Hepatol. 2024 Mar;9(3):251-262.
P0362: Bowel urgency in inflammatory bowel disease: The URGENT indexECCO'25Year: 2025
Authors: Caron, B.(1)*;Bouhnik, Y.(2);Stefanescu, C.(2);Treton, X.(2);Buisson, A.(3);Bourreille, A.(4);Fumery, M.(5);Nachury, M.(6);Roblin, X.(7);Nancey, S.(8);Vicaut, E.(9);Peyrin-Biroulet, L.(1);
(1)Nancy University Hospital, Gastroenterology, Vandoeuvre-lès-Nancy, France;(2)Institut des MICI, Gastroenterology, Neuilly sur Seine, France;(3)Clermont-Ferrand University Hospital, Gastroenterology, Clermont-Ferrand, France;(4)Nantes University Hospital, Gastroenterology, Nantes, France;(5)Amiens University Hospital, Gastroenterology, Amiens, France;(6)Lille University Hospital, Gastroenterology, Lille, France;(7)Saint Etienne University Hospital, Gastroenterology, Saint Etienne, France;(8)Lyon University Hospital, Gastroenterology, Lyon, France;(9)Lariboisière Hospital, Unit of clinical trials, Paris, France;
Caron B, Ghosh S, Danese S, Peyrin-Biroulet L. Identifying, Understanding, and Managing Fecal Urgency in Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2023 Jun;21(6):1403-1413.e27. doi: 10.1016/j.cgh.2023.02.029. Epub 2023 Mar 9. PMID: 36906079.
P0364: Establishment and validation of a central reader pool for magnetic resonance enterography (MRE) for use in Crohn’s disease clinical trialsECCO'25Year: 2025
Authors: Pillay, L.(1)*;Paverd, H.(2);Noor, N.(1);Hickman, K.(2);De Paepe, K.(3);Godfrey, E.M.(2);Khwaja, S.(2);Upponi, S.(2);Kennedy, N.A.(4);Parkes, M.(1);Raine, T.(1);
(1)Cambridge University Hospitals NHS Foundation Trust, Department of Gastroenterology, Cambridge, United Kingdom;(2)Cambridge University Hospitals NHS Foundation Trust, Department of Radiology, Cambridge, United Kingdom;(3)Beth Israel Deaconess Medical Center, Department of Radiology, Boston, United States;(4)Royal Devon and Exeter NHS Foundation Trust, Department of Gastroenterology, Exeter, United Kingdom;
Nurulamin M. Noor et al., "A Biomarker-Stratified Comparison of Top-down versus Accelerated Step-up Treatment Strategies for Patients with Newly Diagnosed Crohn’s Disease (PROFILE): A Multicentre, Open-Label Randomised Controlled Trial," The Lancet Gastroenterology & Hepatology 9, no. 5 (May 1, 2024): 415–27
P0365: The evolution of Geldof fistula class in patients with Crohn's disease perianal fistulaECCO'25Year: 2025
Authors: Ibrahim, F.A.E.(1)*;Sebastian, S.(1);
(1)Hull University Teaching Hospitals - NHS trust, IBD Unit, Hull, United Kingdom; On behalf of GONDOMAR Study group United Kingdom - Email: Hyp-tr.gondomar@nhs.net
(1) Geldof J, Iqbal N, LeBlanc JF, et al. Classifying perianal fistulising Crohn's disease: an expert consensus to guide decision-making in daily practice and clinical trials. Lancet Gastroenterol Hepatol. 2022;7(6):576-584. doi:10.1016/S2468-1253(22)00007-3
P0366: Endoscopic remission in Crohn’s disease, the CREDO trial: Inter-reader variation study of the detection of endoscopic lesions assumed consensually to be related to remission.ECCO'25Year: 2025
Authors: BossuytMD PhD, P.(1)*;Mary, J.Y.(2);Louis, E.(3);Baert, F.(4);Caillo, L.(5);de Suray, N.(6);Dewint, P.(7);Ferrante, M.(8);Filippi, J.(9);Laharie, D.(10);Reenaers, C.(3);SImon, M.(11);Stefanescu, C.(12);Trang, C.(13);Vuitton, L.(14);Vermeire, S.(8);Bouhnik, Y.(12);
(1)Imelda General Hospital Bonheiden, Department of Gastroenterology, Bonheiden, Belgium;(2)Hôpital Saint-Louis, UMR1153 Inserm CRESS- équipe ECSTRRA- SBIM, Paris, France;(3)CHU Liège, Department of gastroenterology, Liège, Belgium;(4)AZ Delta, Department of gastroenterology, Roeselare, Belgium;(5)CHU Nimes, Department of gastroenterology, Nimes, France;(6)Grand Hôpital de Charleroi, Department of gastroenterology, Charleroi, Belgium;(7)AZ Maria Middelares, Department of gastroenterology, Ghent, Belgium;(8)University Hospitals Leuven, Department of gastroenterology and hepatology, Leuven, Belgium;(9)Hopital De L'archet Du Chu De Nice, Department of gastroenterology, Nice, France;(10)CHU Bordeaux, Department of gastroenterology, Bordeaux, France;(11)Institut Mutualiste Montsouris, Department of gastroenterology, Paris, France;(12)Groupe hospitalier privé Ambroise Paré - Hartmann, Institut des mici, Neuilly sur Seine, France;(13)CHU Nantes, Department of gastroenterology, Nantes, France;(14)CHU Besancon, Department of gastroenterology, Besancon, France;
a/ Fleiss J L. Balanced incomplete block design for intra-rater reliability studies. Applied Psychological Measurement 1981; 5: 105-112.b/ Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33:159-75.
